Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/7042
DC FieldValueLanguage
dc.contributor.authorCIONI, CHIARAen_us
dc.contributor.authorTASSI, MARISTELLAen_us
dc.contributor.authorMarotta, Giuseppeen_us
dc.contributor.authorMugnaini, Claudiaen_us
dc.contributor.authorCorelli, Federicoen_us
dc.contributor.authorANNUNZIATA, PASQUALEen_us
dc.date.accessioned2021-03-30T16:08:57Z-
dc.date.available2021-03-30T16:08:57Z-
dc.date.issued2019-
dc.identifier.issn1875-6166en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12779/7042-
dc.description209299en_US
dc.language.isoenen_US
dc.relationNoneen_US
dc.relation.ispartofCENTRAL NERVOUS SYSTEM AGENTS IN MEDICINAL CHEMISTRYen_US
dc.subjectCB2 receptor, Glioma therapy, TGF-beta, anaplastic astrocytoma, cannabinoids, glioblastoma multiformeen_US
dc.titleA novel highly selective cannabinoid CB2 agonist reduces in vitro growth and TGF-beta release of human glial cell tumorsen_US
dc.typeArticleen_US
dc.identifier.doi10.2174/1871524919666190923154351en_US
dc.identifier.pmid31549596en_US
dc.relation.issue19en_US
dc.description.firstpage206en_US
dc.description.lastpage214en_US
dc.description.thirdmissionNot applicableen_US
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
crisitem.author.orcid0000-0003-1998-732X-
crisitem.author.orcid0000-0002-5750-4504-
Appears in Collections:Publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.